The burden of leukemia and related diseases is rapidly growing in Asia. Currently, there is a
paucity of regional collaborative groups/initiatives that focus exclusively on the management …

Background Chimeric antigen receptor natural killer (CAR-NK) cells represent a promising
advancement in CAR cell therapy, addressing limitations observed in CAR-T cell therapy …

Background Childhood leukemia (CL) is a major global concern, accounting for 33% of all
new cancer cases and 31% of all cancer deaths in children aged 0–14 years. Our study …

Background Survivors of childhood acute lymphoblastic leukemia (ALL) are at-risk of
developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by …

目前儿童复发难治性急性淋巴细胞白血病的治疗仍处于困境， 即使提高化疗强度或联合造血
干细胞移植， 仍有部分患儿预后差， 生存期短。 嵌合抗原受体T 细胞（ chimeric antigen …

目的: 分析儿童高白细胞性急性淋巴细胞白血病(ALL) 的临床特征并评估预后. 方法:
回顾性收集2015 年1 月—2020 年6 月诊断的244 例初治ALL 患儿的临床资料, 均按照CCCG …

Across countries in the world, China has the largest population of childhood cancer
survivors. Research and care for the childhood cancer survivor population in China is …

Background Blinatumomab could be successfully used to reduce minimal residual disease
(MRD) prior to hematopoietic stem cell transplantation (HSCT) in pediatric B cell precursor …

Introduction. In childhood, malignant neoplasms are quite rare, which leads to insufficient
alertness of doctors in terms of their early diagnosis. This is especially true for general …

目前儿童复发难治性急性淋巴细胞白血病的治疗仍处于困境, 即使提高化疗强度或联合造血
干细胞移植, 仍有部分患儿预后差, 生存期短. 嵌合抗原受体 T 细胞 (chimeric antigen receptor T …